Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa

Journal of Proteomics

Volumn 74, Issue 9, 2011, Pages 1735-1767

  Williams, David J ^a,b   Gutiérrez, José María ^c   Calvete, Juan J ^d   Wüster, Wolfgang ^e   Ratanabanangkoon, Kavi ^f   Paiva, Owen ^a,b   Brown, Nicholas I ^a   Casewell, Nicholas R ^g   Harrison, Robert A ^g   Rowley, Paul D ^g   O'Shea, Mark ^a,h   Jensen, Simon D ^a,b   Winkel, Kenneth D ^a   Warrell, David A ^a,i  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^d INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

^e BANGOR UNIVERSITY   (United Kingdom)

^f CHULABHORN RESEARCH INSTITUTE   (Thailand)

^g LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^h West Midland Safari Park   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antivenoms; Global Snakebite Initiative; Neglected tropical diseases; Proteomics; Snakebite; Venomics and antivenomics

Indexed keywords

ALPHA COBROTOXIN; ALPHA TOXIN; AMINO ACID; ANTIBODY; ANTIGEN; CYSTEINE; CYSTEINE RICH SECRETORY PROTEIN; CYTOTOXIN; ECHITABG; EPITOPE; ERABUTOXIN A; METALLOPROTEINASE; MITOCHONDRIAL DNA; NEUWIEDASE; NICOTINIC RECEPTOR; PHOSPHOLIPASE A2; POLYCLONAL ANTIBODY; POSTSYNAPTIC NEUROTOXIN; POSTSYNAPTIC NEUROTOXIN ANTIBODY; PROTEIN INHIBITOR; SNAKE VENOM; SNAKE VENOM ANTISERUM; SNAKE VENOM METALLOPROTEINASE; UNCLASSIFIED DRUG;

AFRICA; ANAPHYLAXIS; ANTIBODY PRODUCTION; ANTIVENOMICS; ASIA; BIOTECHNOLOGY; BITIS ARIETANS VENOM; BITIS GABONICA; BITIS NASICORNIS; BITIS RHINOCEROS; BLEEDING; BLISTER; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; DEATH; DISULFIDE BOND; DNA SEQUENCE; DRUG ACTIVITY; DRUG COST; DRUG DESIGN; DRUG EFFICACY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; DRUG SCREENING; ECHIS LEUCOGASTER; ECHIS OCELLATUS; ECHIS PYRAMIDUM LEAKEYI; EDEMA; ELECTROSPRAY MASS SPECTROMETRY; ENVENOMATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNDING; HAPLOTYPE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DISPARITY; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH PROMOTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTORY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOREACTIVITY; IMMUNOTHERAPY; INDIA; LETHALITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; MORBIDITY; MORTALITY; MYANMAR; NERVE ENDING; NUCLEOTIDE SEQUENCE; PAPUA NEW GUINEA; PARALYSIS; PHYLOGENY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEOMICS; PUBLIC HEALTH; QUALITY CONTROL; RECEPTOR BINDING; RESPIRATORY FAILURE; REVIEW; RISK REDUCTION; SNAKE; SNAKE VENOMICS; SNAKEBITE; SOUTH AND CENTRAL AMERICA; SPECIES IDENTIFICATION; THAILAND; TISSUE INJURY; TISSUE NECROSIS; TOXIN STRUCTURE; WESTERN BLOTTING;

AFRICA; ANTIVENINS; ASIA; DELIVERY OF HEALTH CARE; HUMANS; ORGANIZATIONS; PROTEOMICS; SNAKE BITES; WORLD HEALTH ORGANIZATION;

SERPENTES;

EID: 80051670140     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.05.027     Document Type: Review

References (261)

1. Nawarak J., Sinchaikul S., Wu C.Y., Liau M.Y., Phutrakul S., Chen S.T. Proteomics of snake venoms from Elapidae and Viperidae families by multidimensional chromatographic methods. Electrophoresis 2003, 24:2838-2854.
2. Li S., Wang J., Zhang X., Ren Y., Wang N., Zhao K., et al. Proteomic characterization of two snake venoms: Naja naja atra and Agkistrodon halys. Biochem J 2004, 384:119-127.
3. Bazaa A., Marrakchi N., El Ayeb M., Sanz L., Calvete J.J. Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Proteomics 2005, 5:4223-4235.
4. Serrano S.M., Shannon J.D., Wang D., Camargo A.C., Fox J.W. A multifaceted analysis of viperid snake venoms by two-dimensional gel electrophoresis: an approach to understanding venom proteomics. Proteomics 2005, 5:501-510.
5. Birrell G.W., Earl S., Masci P.P., de Jersey J., Wallis T.P., Gorman J.J., et al. Molecular diversity in venom from the Australian Brown snake, Pseudonaja textilis. Mol Cell Proteomics 2006, 5:379-389.
6. Earl S.T., Birrell G.W., Wallis T.P., St Pierre L.D., Masci P.P., de Jersey J., et al. Post-translational modification accounts for the presence of varied forms of nerve growth factor in Australian elapid snake venoms. Proteomics 2006, 6:6554-6565.
7. Fox J.W., Ma L., Nelson K., Sherman N.E., Serrano S.M. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes. Toxicon 2006, 47:700-714.
8. Calvete J.J., Juarez P., Sanz L. Snake venomics. Strategy and applications. J Mass Spectrom 2007, 42:1405-1414.
9. Birrell G.W., Earl S.T., Wallis T.P., Masci P.P., de Jersey J., Gorman J.J., et al. The diversity of bioactive proteins in Australian snake venoms. Mol Cell Proteomics 2007, 6:973-986.
10. St Pierre L., Birrell G.W., Earl S.T., Wallis T.P., Gorman J.J., de Jersey J., et al. Diversity of toxic components from the venom of the evolutionarily distinct black whip snake, Demansia vestigiata. J Proteome Res 2007, 6:3093-3107.
11. Calvete J.J., Escolano J., Sanz L. Snake venomics of Bitis species reveals large intragenus venom toxin composition variation: application to taxonomy of congeneric taxa. J Proteome Res 2007, 6:2732-2745.
12. Yanes O., Aviles F.X., Wenzel R., Nazabal A., Zenobi R., Calvete J.J. Proteomic profiling of a snake venom using high mass detection MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom 2007, 18:600-606.
13. Calvete J.J., Marcinkiewicz C., Sanz L. Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2. J Proteome Res 2007, 6:326-336.
14. Georgieva D., Risch M., Kardas A., Buck F., von Bergen M., Betzel C. Comparative analysis of the venom proteomes of Vipera ammodytes ammodytes and Vipera ammodytes meridionalis. J Proteome Res 2008, 7:866-886.
15. Sanz L., Escolano J., Ferretti M., Biscoglio M.J., Rivera E., Crescenti E.J., et al. Snake venomics of the South and Central American Bushmasters. Comparison of the toxin composition of Lachesis muta gathered from proteomic versus transcriptomic analysis. J Proteomics 2008, 71:46-60.
16. Olamendi-Portugal T., Batista C.V., Restano-Cassulini R., Pando V., Villa-Hernandez O., Zavaleta-Martinez-Vargas A., et al. Proteomic analysis of the venom from the fish eating coral snake Micrurus surinamensis: novel toxins, their function and phylogeny. Proteomics 2008, 8:1919-1932.
17. Tashima A.K., Sanz L., Camargo A.C., Serrano S.M., Calvete J.J. Snake venomics of the Brazilian pitvipers Bothrops cotiara and Bothrops fonsecai. Identification of taxonomy markers. J Proteomics 2008, 71:473-485.
18. Sanz L., Ayvazyan N., Calvete J.J. Snake venomics of the Armenian mountain vipers Macrovipera lebetina obtusa and Vipera raddei. J Proteomics 2008, 71:198-209.
19. Ferreira BL, Santos DO, Santos AL, Rodrigues CR, de Freitas CC, Cabral LM, et al. Comparative analysis of Viperidae venoms antibacterial profile: a short communication for proteomics. Evid Based Complement Alternat Med in press; http://doi:10.1093/ecam/nen052.
20. Alape-Giron A., Flores-Diaz M., Sanz L., Madrigal M., Escolano J., Sasa M., et al. Studies on the venom proteome of Bothrops asper: perspectives and applications. Toxicon 2009, 54:938-948.
21. Gibbs H.L., Sanz L., Calvete J.J. Snake population venomics: proteomics-based analyses of individual variation reveals significant gene regulation effects on venom protein expression in Sistrurus rattlesnakes. J Mol Evol 2009, 68:113-125.
22. Terra R.M., Pinto A.F., Guimaraes J.A., Fox J.W. Proteomic profiling of snake venom metalloproteinases (SVMPs): insights into venom induced pathology. Toxicon 2009, 54:836-844.
23. Risch M., Georgieva D., von Bergen M., Jehmlich N., Genov N., Arni R.K., et al. Snake venomics of the Siamese Russell's viper (Daboia russelli siamensis) - relation to pharmacological activities. J Proteomics 2009, 72:256-269.
24. Calvete J.J., Fasoli E., Sanz L., Boschetti E., Righetti P.G. Exploring the venom proteome of the western diamondback rattlesnake, Crotalus atrox, via snake venomics and combinatorial peptide ligand library approaches. J Proteome Res 2009, 8:3055-3067.
25. Paes Leme A.F., Kitano E.S., Furtado M.F., Valente R.H., Camargo A.C., Ho P.L., et al. Analysis of the subproteomes of proteinases and heparin-binding toxins of eight Bothrops venoms. Proteomics 2009, 9:733-745.
26. Wagstaff S.C., Sanz L., Juarez P., Harrison R.A., Calvete J.J. Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus. J Proteomics 2009, 71:609-623.
27. Ohler M., Georgieva D., Seifert J., von Bergen M., Arni R.K., Genov N., et al. The venomics of Bothrops alternatus is a pool of acidic proteins with predominant hemorrhagic and coagulopathic activities. J Proteome Res 2010, 9:2422-2437.
28. Georgieva D., Ohler M., Seifert J., von Bergen M., Arni R.K., Genov N., et al. Snake venomic of Crotalus durissus terrificus-correlation with pharmacological activities. J Proteome Res 2010, 9:2302-2316.
29. Fasoli E., Sanz L., Wagstaff S., Harrison R.A., Righetti P.G., Calvete J.J. Exploring the venom proteome of the African puff adder, Bitis arietans, using a combinatorial peptide ligand library approach at different pHs. J Proteomics 2010, 73:932-942.
30. Currier R.B., Harrison R.A., Rowley P.D., Laing G.D., Wagstaff S.C. Intra-specific variation in venom of the African Puff Adder (Bitis arietans): differential expression and activity of snake venom metalloproteinases (SVMPs). Toxicon 2010, 55:864-873.
31. Cardoso K.C., Da Silva M.J., Costa G.G., Torres T.T., Del Bem L.E., Vidal R.O., et al. A transcriptomic analysis of gene expression in the venom gland of the snake Bothrops alternatus (urutu). BMC Genomics 2010, 11:605.
32. Liu S., Yang F., Zhang Q., Sun M.Z., Gao Y., Shao S. "Anatomical" view of the protein composition and protein characteristics for Gloydius shedaoensis snake venom via proteomics approach. Anat Rec (Hoboken) 2011, 294:273-282.
33. Alape-Giron A., Sanz L., Escolano J., Flores-Diaz M., Madrigal M., Sasa M., et al. Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations. J Proteome Res 2008, 7:3556-3571.
34. Fernandez J., Lomonte B., Sanz L., Angulo Y., Gutierrez J.M., Calvete J.J. Snake venomics of Bothriechis nigroviridis reveals extreme variability among palm pitviper venoms: different evolutionary solutions for the same trophic purpose. J Proteome Res 2010, 9:4234-4241.
35. GuimarãesãGomes V., Oliveira-Carvalho A.L., Junqueira-de-Azevedo I.L., S Dutra D.L., Pujol-Luz M., Castro H.C., et al. Cloning, characterization, and structural analysis of a C-type lectin from Bothrops insularis (BiL) venom. Arch Biochem Biophys 2004, 432:1-11.
36. Tsai I.H., Chen Y.H., Wang Y.M. Comparative proteomics and subtyping of venom phospholipases A2 and disintegrins of Protobothrops pit vipers. Biochim Biophys Acta 2004, 1702:111-119.
37. Oliveira-Carvalho A.L., Guimaraes P.R., Abreu P.A., Dutra D.L., Junqueira-de-Azevedo I.L., Rodrigues C.R., et al. Identification and characterization of a new member of snake venom thrombin inhibitors from Bothrops insularis using a proteomic approach. Toxicon 2008, 51:659-671.
38. Sun M.Z., Liu S., Yang F., Greenaway F.T., Xu Y. A novel phospholipase A2 from Agkistrodon blomhoffii ussurensis venom: purification, proteomic, functional and structural characterizations. Biochimie 2009, 91:558-567.
39. Nunez V., Cid P., Sanz L., De La Torre P., Angulo Y., Lomonte B., et al. Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Peru and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism. J Proteomics 2009, 73:57-78.
40. Boldrini-Franca J., Correa-Netto C., Silva M.M., Rodrigues R.S., De La Torre P., Perez A., et al. Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management. J Proteomics 2010, 73:1758-1776.
41. Sanz L., Gibbs H.L., Mackessy S.P., Calvete J.J. Venom proteomes of closely related Sistrurus rattlesnakes with divergent diets. J Proteome Res 2006, 5:2098-2112.
42. Angulo Y., Escolano J., Lomonte B., Gutierrez J.M., Sanz L., Calvete J.J. Snake venomics of Central American pitvipers: clues for rationalizing the distinct envenomation profiles of Atropoides nummifer and Atropoides picadoi. J Proteome Res 2008, 7:708-719.
43. Lomonte B., Escolano J., Fernandez J., Sanz L., Angulo Y., Gutierrez J.M., et al. Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii. J Proteome Res 2008, 7:2445-2457.
44. Jurgens M., Schrader M. Peptidomic approaches in proteomic research. Curr Opin in Molecular Therapeutics 2002, 4:236-241.
45. Fox J.W., Serrano S.M. Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures. Proteomics 2008, 8:909-920.
46. Georgieva D., Arni R.K., Betzel C. Proteome analysis of snake venom toxins: pharmacological insights. Expert Rev Proteomics 2008, 5:787-797.
47. Gutierrez J.M., Lomonte B., Leon G., Alape-Giron A., Flores-Diaz M., Sanz L., et al. Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics 2009, 72:165-182.
48. Fox J.W., Serrano S.M. Timeline of key events in snake venom metalloproteinase research. J Proteomics 2009, 72:200-209.
49. Calvete J.J., Sanz L., Angulo Y., Lomonte B., Gutierrez J.M. Venoms, venomics, antivenomics. FEBS Lett 2009, 583:1736-1743.
50. Righetti P.G., Boschetti E., Zanella A., Fasoli E., Citterio A. Plucking, pillaging and plundering proteomes with combinatorial peptide ligand libraries. J Chromatogr A 2010, 1217:893-900.
51. Calvete J.J. Antivenomics and venom phenotyping: a marriage of convenience to address the performance and range of clinical use of antivenoms. Toxicon 2010, 56:1284-1291.
52. Calvete J.J., Borges A., Segura A., Flores-Diaz M., Alape-Giron A., Gutierrez J.M., et al. Snake venomics and antivenomics of Bothrops colombiensis, a medically important pitviper of the Bothrops atrox-asper complex endemic to Venezuela: contributing to its taxonomy and snakebite management. J Proteomics 2009, 72:227-240.
53. Espino-Solis G.P., Riano-Umbarila L., Becerril B., Possani L.D. Antidotes against venomous animals: state of the art and prospectives. J Proteomics 2009, 72:183-199.
54. Calvete J.J., Cid P., Sanz L., Segura A., Villalta M., Herrera M., et al. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa. Am J Trop Med Hyg 2010, 82:1194-1201.
55. Correa-Netto C., Teixeira-Araujo R., Aguiar A.S., Melgarejo A.R., De-Simone S.G., Soares M.R., et al. Immunome and venome of Bothrops jararacussu: a proteomic approach to study the molecular immunology of snake toxins. Toxicon 2010, 55:1222-1235.
56. Harrison R.A., Hargreaves A., Wagstaff S.C., Faragher B., Lalloo D.G. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis 2009, 3:e569.
57. Brown N., Landon J. Antivenom: the most cost-effective treatment in the world?. Toxicon 2010, 55:1405-1407.
58. Meyer W.P., Habib A.G., Onayade A.A., Yakubu A., Smith D.C., Nasidi A., et al. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg 1997, 56:291-300.
59. Theakston R.D., Warrell D.A. Crisis in snake antivenom supply for Africa. Lancet 2000, 356:2104.
60. Wilde H., Thipkong P., Sitprija V., Chaiyabutr N. Heterologous antisera and antivenins are essential biologicals: perspectives on a worldwide crisis. Ann Intern Med 1996, 125:233-236.
61. Theakston R.D., Warrell D.A., Griffiths E. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 2003, 41:541-557.
62. Warrell D.A. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-'what's in a name?'. Trans R Soc Trop Med Hyg 2008, 102:397-399.
63. Bregani E.R., Maraffi T., Van Tien T. Snake bites in Moyen Chari district, Chad: a five-year experience. Trop Doct 2011, 41:123-126.
64. Ariaratnam C.A., Sjostrom L., Raziek Z., Kularatne S.A., Arachchi R.W., Sheriff M.H., et al. An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg 2001, 95:74-80.
65. Phillips R.E., Theakston R.D., Warrell D.A., Galigedara Y., Abeysekera D.T., Dissanayaka P., et al. Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med 1988, 68:691-715.
66. Williams DJ, Jensen SD, O'Shea MT. Snakebite management in Cambodia: towards improved prevention, clinical treatment and rehabilitation. Report for WHO WPRO and Cambodian Ministry of, Health 2009:1-70.
67. Seng N. Bad medicine. The Irrawaddy 2003, 2. http://www.irrawaddy.org/article.php?art_id=2805&page=1.
68. World Health Organisation Guidelines for the production, regulation and control of snake antivenom immunoglobulins 2010, 1-134. World Health Organisation, Geneva. First Ed.
69. Williams D.J., Gutierrez J.M., Harrison R., Warrell D.A., White J., Winkel K.D., et al. The Global Snake Bite Initiative: an antidote for snake bite. Lancet 2010, 375:89-91.
70. Gutierrez J.M., Williams D.J., Fan H.W., Warrell D.A. Snakebite envenoming from a global perspective: towards an integrated approach. Toxicon 2010, 56:1223-1235.
71. Sewall H. Experiments on the preventive inoculation of rattlesnake venom. J Physiol 1887, 8:203-210.
72. Hawgood B.J. Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination. Toxicon 1999, 37:1241-1258.
73. Calmette A. Contribution à l'étude du venin des serpents. Immunisation des animaux et traitement de l'envenimation. Annales de l'Institut Pasteur 1894, 8:275-291.
74. Calmette A. L'immunisation artificielle des animaux contre le venin des serpents, et la thérapeutic expérimentale des morsures venimeuses. Comptes Rendus de la Société de Biologie 1894, 46:120-124.
75. Phisalix C., Bertrand G. Sur la propriété antitoxique du sang des animaux vaccinée contre le venin de vipére. Comptes Rendus de la Socie te de Biologie 1894, 46:111.
76. Calmette A. Contribution à l'étude des venins, des toxines et des sérums antitoxiques. Annales de l'Institut Pasteur 1895, 9:225-251.
77. Calmette A. The treatment of animals poisoned with snake venom by the injection of anti-venomous serum. Lancet 1896, ii:449-450.
78. Hawgood B.J. Pioneers of anti-venomous serotherapy: Dr Vital Brazil (1865-1950). Toxicon 1992, 30:573-579.
79. Winkel K.D., Mirtschin P., Pearn J. Twentieth century toxinology and antivenom development in Australia. Toxicon 2006, 48:738-754.
80. Martin C.J. An explanation of the marked differences in the effects produced by subcutaneous and intravenous injection of the venom of Australian snakes. J Roy Soc NSW 1896, 30:150-157.
81. Martin C.J. The curative value of Calmette's anti-venomous serum in the treatment of inoculations with the poisons of Australian snakes. Intercolon Med J Aust 1897, 2:527-536.
82. Martin C.J. On the advisability of administering curative serum by intravenous injection. Intercolon Med J Aust 1897, 2:537-538.
83. Martin C.J. Further observations concerning the relation of the toxin and antitoxin of snake venom. Proc R Soc Lond 1898, 64:88-94.
84. Martin C.J., Cherry T. The nature of the antagonism between toxins and antitoxins. Proc R Soc Lond 1898, 63:420-432.
85. Martin C.J. The contribution of experiments with snake venom to the development of our knowledge of immunity. Discussion on immunity. Br Med J 1904, ii:574-577.
86. Grasset E. Survey of assay methods of antivenins; immunological factors influencing antivenin standardization. Bull World Health Organ 1957, 16:79-122. [Bulletin of the World Health Organization].
87. Hawgood B.J. Poul Agerholm Christensen MD (1912-1991): antivenom production at the South African Institute for Medical Research. Toxicon 2001, 39:749-756.
88. Coulter A., Harris R. Simplified preparation of rabbit Fab fragments. J Immunol Methods 1983, 59:199-203. [Journal of immunological methods].
89. Smith D.C., Reddi K.R., Laing G., Theakston R.G., Landon J. An affinity purified ovine antivenom for the treatment of Vipera berus envenoming. Toxicon 1992, 30:865-871.
90. Ariaratnam C.A., Meyer W.P., Perera G., Eddleston M., Kuleratne S.A., Attapattu W., et al. A new monospecific ovine Fab fragment antivenom for treatment of envenoming by the Sri Lankan Russell's viper (Daboia russelii russelii): a preliminary dose-finding and pharmacokinetic study. Am J Trop Med Hyg 1999, 61:259-265.
91. Seifert S.A., Boyer L.V. Recurrence phenomena after immunoglobulin therapy for snake envenomations: part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies. Ann Emerg Med 2001, 37:189-195.
92. Morais J.F., de Freitas M.C.W., Yamaguchi I.K., dos Santos M.C., da Silva W.D. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments. Toxicon 1994, 32:725-734.
93. dos_Santos M.C., D_Imperio_Lima M.R., Furtado G.C., Colletto G.M., Kipnis T.L., Dias_da_Silva W. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield. Toxicon 1989, 27:297-303.
94. Rojas G., Jimenez J.M., Gutierrez J.M. Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production. Toxicon 1994, 32:351-363.
95. Burnouf T., Griffiths E., Padilla A., Seddik S., Stephano M.A., Gutierrez J.M. Assessment of the viral safety of antivenoms fractionated from equine plasma. Biologicals 2004, 32:115-128.
96. Winkel K.D. The effects of privatisation of the commonwealth serum laboratories on venom and antivenom research and development in Australia. A submission to the House of Representatives Standing Committee on Industry, Science and Technology Parliamentary Inquiry into the Effects on Research and Development of Public Policy Reform in the Last Decade 1998, University of Melbourne, Melbourne. Parliament of Australia: Standing Committee on Industry SaR (Ed.).
97. Stock R.P., Massougbodji A., Alagon A., Chippaux J.P. Bringing antivenoms to Sub-Saharan Africa. Nat Biotechnol 2007, 25:173-177.
98. Warrell D.A. Clinical snake bite problems in the Nigerian savanna region. Technische Hochschule Darmstadt Schriftenreihe Wissenschaft u-Technik 1979, 14:31-60.
99. Warrell D.A., Davidson N.M., Omerod L.D., Pope H.M., Watkins B.J., Greenwood B.M., et al. Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms. Br Med J 1974, 4:437-440.
100. Chippaux J.P., Lang J., Eddine S.A., Fagot P., Rage V., Peyrieux J.C., et al. Clinical safety of a polyvalent F(ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans R Soc Trop Med Hyg 1998, 92:657-662.
101. Chippaux J.P., Lang J., Amadi-Eddine S., Fagot P., Le Mener V. Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon. Am J Trop Med Hyg 1999, 61:1017-1018.
102. Warrell D.A., Arnett C. The importance of bites by the saw-scaled or carpet viper (Echis carinatus): epidemiological studies in Nigeria and a review of the world literature. Acta Trop 1976, 33:307-341.
103. Lalloo D.G., Theakston R.D., Warrell D.A. The African challenge. Lancet 2002, 359:1527.
104. Laing G.D., Harrison R.A., Theakston R.D., Renjifo J.M., Nasidi A., Gutierrez J.M., et al. Polyspecific snake antivenom may help in antivenom crisis. BMJ 2003, 326:447.
105. Visser L.E., Kyei-Faried S., Belcher D.W., Geelhoed D.W., van Leeuwen J.S., van Roosmalen J. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg 2008, 102:445-450.
106. Warrell D.A., Williams D. Response to comment on: failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg 2009, 103:965-966.
107. Laing G.D., Renjifo J.M., Ruiz F., Harrison R.A., Nasidi A., Gutierrez J.-M., et al. A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa. Toxicon 2003, 42:35-41.
108. Gutierrez J.M., Rojas E., Quesada L., Leon G., Nunez J., Laing G.D., et al. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa. Trans R Soc Trop Med Hyg 2005, 99:468-475.
109. Chippaux J.P., Massougbodji A., Stock R.P., Alagon A. Clinical trial of an F(ab')2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg 2007, 77:538-546.
110. Segura A., Villalta M., Herrera M., Leon G., Harrison R., Durfa N., et al. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 2010, 55:369-374.
111. Coombs M.D., Dunachie S.J., Brooker S., Haynes J., Church J., Warrell D.A. Snake bites in Kenya: a preliminary survey of four areas. Trans R Soc Trop Med Hyg 1997, 91:319-321.
112. Chippaux J.P., Ramos-Cerrillo B., Stock R.P. Study of the efficacy of the black stone on envenomation by snake bite in the murine model. Toxicon 2007, 49:717-720.
113. Sharma N., Chauhan S., Faruqi S., Bhat P., Varma S. Snake envenomation in a north Indian hospital. Emerg Med J 2005, 22:118-120. [Emergency medicine journal: EMJ].
114. Agrawal P.N., Aggarwal A.N., Gupta D., Behera D., Prabhakar S., Jindal S.K. Management of respiratory failure in severe neuroparalytic snake envenomation. Neurol India 2001, 49:25-28.
115. Suchithra N., Pappachan J.M., Sujathan P. Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes. Emerg Med J 2008, 25:200-204.
116. Theakston R.D., Phillips R.E., Warrell D.A., Galagedera Y., Abeysekera D.T., Dissanayaka P., et al. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans R Soc Trop Med Hyg 1990, 84:301-308.
117. Warrell D.A., Looareesuwan S., Theakston R.D., Phillips R.E., Chanthavanich P., Viravan C., et al. Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. Am J Trop Med Hyg 1986, 35:1235-1247.
118. Pratanaphon R., Akesowan S., Khow O., Sriprapat S., Ratanabanangkoon K. Production of highly potent horse antivenom against the Thai cobra (Naja kaouthia). Vaccine 1997, 15:1523-1528.
119. Chotwiwatthanakun C., Pratanaphon R., Akesowan S., Sriprapat S., Ratanabanangkoon K. Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol. Toxicon 2001, 39:1487-1494.
120. Sriprapat S., Aeksowan S., Sapsutthipas S., Chotwiwatthanakun C., Suttijitpaisal P., Pratanaphon R., et al. The impact of a low dose, low volume, multi-site immunization on the production of therapeutic antivenoms in Thailand. Toxicon 2003, 41:57-64.
121. Thiansookon A., Rojnuckarin P. Low incidence of early reactions to horse-derived F(ab')(2) antivenom for snakebites in Thailand. Acta Trop 2008, 105:203-205.
122. Tan N.H., Fung S.Y., Ponnudurai G. Enzymatic and immunological properties of Bungarus flaviceps (red-headed krait) venom. J of Venom Animals and Toxins including Tropical Dis 2010, 16:147-154.
123. Lalloo D.G., Trevett A.J., Korinhona A., Nwokolo N., Laurenson I.F., Paul M., et al. Snake bites by the Papuan Taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom. Am J Trop Med Hyg 1995, 52:525-531.
124. Lalloo D.G., Trevett A.J., Black J., Mapao J., Saweri A., Naraqi S., et al. Neurotoxicity, anticoagulant activity and evidence of rhabdomyolysis in patients bitten by death adders (Acanthophis sp.) in southern Papua New Guinea. QJM 1996, 89:25-35.
125. Currie B., Vince J., Naraqi S. Snake bite in Papua New Guinea. P N G Med J 1988, 31:195-198.
126. Williams D.J. Proposal for establishment of a national antivenom unit: submission to the Government of the Independent State of Papua New Guinea 2007, 1-150. University of Melbourne, Melbourne.
127. Warrell D.A. Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product-'what's in a name?'. Trans R Soc Trop Med Hyg 2008, 102:397-399.
128. Vargas M., Segura A., Herrera M., Villalta M., Estrada R., Cerdas M., et al. Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. PLoS Negl Trop Dis 2011, 5:e1144.
129. Gutierrez J.M., Higashi H.G., Wen F.H., Burnouf T. Strengthening antivenom production in Central and South American public laboratories: report of a workshop. Toxicon 2007, 49:30-35.
130. Segura A., Castillo M.C., Nunez V., Yarleque A., Goncalves L.R., Villalta M., et al. Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms. Toxicon 2010, 56:980-989.
131. Theakston R.D., Laing G.D., Fielding C.M., Lascano A.F., Touzet J.M., Vallejo F., et al. Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms. Trans R Soc Trop Med Hyg 1995, 89:550-554.
132. Thomas L., Tyburn B., Lang J., Ketterle J. Early infusion of a purified monospecific F(ab')2 antivenom serum for Bothrops lanceolatus bites in Martinique. Lancet 1996, 347:406.
133. Gutierrez J.M., Fan H.W., Silvera C.L., Angulo Y. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop. Toxicon 2009, 53:625-630.
134. Meyer W.P., Habib A.G., Onayade A.A., Yakubu A., Smith D.C., Nasidi A., et al. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg 1997, 56:291-300.
135. Abubakar I.S., Abubakar S.B., Habib A.G., Nasidi A., Durfa N., Yusuf P.O., et al. Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis 2010, 4:e767.
136. Chippaux J.P. Snake-bites: appraisal of the global situation. Bull World Health Organ 1998, 76:515-524.
137. Kasturiratne A., Wickremasinghe A.R., de Silva N., Gunawardena N.K., Pathmeswaran A., Premaratna R., et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008, 5:e218.
138. Rahman R., Faiz M.A., Selim S., Rahman B., Basher A., Jones A., et al. Annual incidence of snake bite in rural Bangladesh. PLoS Negl Trop Dis 2010, 4:e860.
139. Mohapatra B., Warrell D.A., Suraweera W., Bhatia P., Dhingra N., Jotkar R.M., et al. Snakebite mortality in India: a nationally representative mortality survey. PLoS Negl Trop Dis 2011, 5:e1018.
140. Fry B.G., Roelants K., Champagne D.E., Scheib H., Tyndall J.D., King G.F., et al. The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 2009, 10:483-511.
141. Kini R.M., Doley R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon 2010, 56:855-867.
142. Casewell N.R., Cook D.A., Wagstaff S.C., Nasidi A., Durfa N., Wüster W., et al. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom. PLoS Negl Trop Dis 2010, 4:e851.
143. Rawat S., Laing G., Smith D.C., Theakston D., Landon J. A new antivenom to treat Eastern Coral Snake (Micrurus fulvius fulvius) envenoming. Toxicon 1994, 32:185-190.
144. Hayter J.R., Robertson D.H., Gaskell S.J., Beynon R.J. Proteome analysis of intact proteins in complex mixtures. Mol Cell Proteomics 2003, 2:85-95.
145. Abubakar S.B., Abubakar I.S., Habib A.G., Nasidi A., Durfa N., Yusuf P.O., et al. Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon 2010, 55:719-723.
146. Cook D.A., Owen T., Wagstaff S.C., Kinne J., Wernery U., Harrison R.A. Analysis of camelid antibodies for antivenom development: neutralisation of venom-induced pathology. Toxicon 2010, 56:373-380.
147. Cook D.A., Owen T., Wagstaff S.C., Kinne J., Wernery U., Harrison R.A. Analysis of camelid IgG for antivenom development: serological responses
148. Wagstaff S.C., Harrison R.A. Venom gland EST analysis of the saw-scaled viper, Echis ocellatus, reveals novel alpha9beta1 integrin-binding motifs in venom metalloproteinases and a new group of putative toxins, renin-like aspartic proteases. Gene 2006, 377:21-32.
149. Casewell N.R., Harrison R.A., Wüster W., Wagstaff S.C. Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts. BMC Genomics 2009, 10:564.
150. Kuch U., Kizirian D., Truong N.Q., Lawson R., Donnelly M.A., Mebs D. A new species of krait (Squamata: Elapidae) from the Red River System of Northern Vietnam. Copeia 2005, 818-833.
151. Wüster W., Broadley D.G. Get an eyeful of this: a new species of giant spitting cobra from eastern and north-eastern Africa (Squamata: Serpentes: Elapidae: Naja). Zootaxa 2007, 1532:51-68.
152. Sanders K.L., Malhotra A., Thorpe R.S. Combining molecular, morphological and ecological data to infer species boundaries in a cryptic tropical pitviper. Biol J Linn Soc 2006, 87:343-364.
153. Trape J.-F., Chirio L., Broadley D.G., Wüster W. Phylogeography and systematic revision of the Egyptian cobra (Serpentes: Elapidae: Naja haje) species complex, with the description of a new species from West Africa. Zootaxa 2009, 2236:1-25.
154. Malhotra A., Dawson K., Guo P., Thorpe R.S. Phylogenetic structure and species boundaries in the mountain pitviper Ovophis monticola (Serpentes: Viperidae: Crotalinae) in Asia. Mol Phylogenet Evol 2011, 59:444-457.
155. Puorto G., Salomão M.G., Theakston R.D.G., Thorpe R.S., Warrell D.A., Wüster W. Combining mitochondrial DNA sequences and morphological data to infer species boundaries: phylogeography of lanceheaded pitvipers in the Brazilian Atlantic forest, and the status of Bothrops pradoi (Squamata: Serpentes: Viperidae). J Evol Biol 2001, 14:527-538.
156. Castoe T.A., Smith E.N., Brown R.M., Parkinson C.L. Higher-level phylogeny of Asian and American coralsnakes, their placement within the Elapidae (Squamata), and the systematic affinities of the enigmatic Asian coralsnake Hemibungarus calligaster (Wiegmann, 1834). Zoological J of the Linnean Soc 2007, 151:809-831.
157. Castoe T.A., Parkinson C.L. Bayesian mixed models and the phylogeny of pitvipers (Viperidae: Serpentes). Mol Phylogenet Evol 2006, 39:91-110.
158. Wüster W., Peppin L., Pook C.E., Walker D.E. A nesting of vipers: phylogeny and historical biogeography of the Viperidae (Squamata: Serpentes). Mol Phylogenet Evol 2008, 49:445-459.
159. Slowinski J.B., Keogh J.S. Phylogenetic relationships of elapid snakes based on cytochrome b mtDNA sequences. Mol Phylogenet Evol 2000, 15:157-164.
160. Sanders K.L., Lee M.S.Y., Leys R., Foster R., Keogh S.J. Molecular phylogeny and divergence dates for Australasian elapids and sea snakes (Hydrophiinae): evidence from seven genes for rapid evolutionary radiations. J Evol Biol 2008, 21:682-695.
161. Vidal N., Rage J.-C., Couloux A., Hedges S.B. Snakes (Serpentes). The timetree of life 2009, 390-397. Oxford University Press, Oxford. S.B. Hedges, S. Kumar (Eds.).
162. Pyron R.A., Burbrink F.T., Colli G.R., Montes de Oca A.M., Kuczynski C.A., Wiens J.J. The phylogeny of advanced snakes (Colubroidea), with discovery of a new subfamily and comparison of support methods for likelihood trees. Mol Phylogenet Evol 2011, 58:329-342.
163. Karlsson E., Eaker D.L., Porath J. Purification of a neurotoxin from the venom of Naja nigricollis. Biochim Biophys Acta 1966, 127:505-520.
164. Nirthanan S., Gwee M.C. Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on. J Pharmacol Sci 2004, 94:1-17. [Journal of pharmacological sciences].
165. Fruchart-Gaillard C., Menez A., Servent D. Critical role of peptidic toxins in the functional and structural analysis of nicotinic acetylcholine receptors. J Soc Biol 2005, 199:45-53.
166. Petras D., Sanz L., Segura A., Herrera M., Villalta M., Solano D., et al. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the Pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches. J Proteome Res 2011, 10:1266-1280.
167. Branch W.R. The venomous snakes of southern Africa. Part 2. Elapidae and Hydrophiidae. Snake 1979, 11:199-225.
168. Hughes B. African snake faunas. Bonn Zool Beitr 1983, 34:311-356.
169. Wüster W., Crookes S., Ineich I., Mane Y., Pook C.E., Trape J.F., et al. The phylogeny of cobras inferred from mitochondrial DNA sequences: evolution of venom spitting and the phylogeography of the African spitting cobras (Serpentes: Elapidae: Naja nigricollis complex). Mol Phylogenet Evol 2007, 45:437-453.
170. Wüster W., Broadley D.G. A new species of spitting cobra from northeastern Africa (Serpentes: Elapidae: Naja). J Zool Lond 2003, 259:345-359.
171. Viravan C., Looareesuwan S., Kosakarn W., Wuthiekanun V., McCarthy C.J., Stimson A.F., et al. A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg 1992, 86(1):100-106.
172. Wüster W., Warrell D.A., Cox M.J., Jintakune P., Nabhitabhata J. Redescription of Naja siamensis Laurenti, 1768 (Serpentes: Elapidae), a widely overlooked spitting cobra from Southeast Asia: geographic variation, medical importance and designation of a neotype. J Zool Lond 1997, 243:771-788.
173. Pook C.E., McEwing R. Mitochondrial DNA sequences from dried snake venom: a DNA barcoding approach to the identification of venom samples. Toxicon 2005, 46:711-715.
174. Warrell D.A. Geographical and interspecies variation in the clinical manifestations of envenoming by snakes. Symposia Zool Soc of London 1997, 70:189-203.
175. Fry B.G., Winkel K.D., Wickramaratna J.C., Hodgson W.C., Wüster W. Effectiveness of snake antivenom: species and regional venom variation and its clinical impact. J of Toxicology: Toxin Reviews 2003, 22:23-34.
176. Wüster W., Thorpe R.S., Salomão M.G., Thomas L., Puorto G., Theakston R.D.G., et al. Origin and phylogenetic position of the Lesser Antillean species of Bothrops (Serpentes: Viperidae): biogeographical and medical implications. Bulletin of the Nat Hist Museum London (Zoology) 2002, 68:101-106.
177. Thorpe R.S., Pook C.E., Malhotra A. Phylogeography of the Russell's viper (Daboia russelii) complex in relation to variation in the colour pattern and symptoms of envenoming. Herpetol J 2007, 17:209-218.
178. Harrison R.A., Wüster W., Theakston R.D. The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody. Toxicon 2003, 41:441-449.
179. Petras D., Sanz L., Segura A., Herrera M., Villalta M., Solano D., et al. Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the Pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches. J Proteome Res 2011, 10:1266-1280.
180. Gillissen A., Theakston R.D.G., Barth J., May B., Krieg M., Warrell D.A. Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis 'pyramidum'-complex): failure of antivenom treatment. Toxicon 1994, 32:937-944.
181. Pook C.E., Joger U., Stumpel N., Wüster W. When continents collide: phylogeny, historical biogeography and systematics of the medically important viper genus Echis (Squamata: Serpentes: Viperidae). Mol Phylogenet Evol 2009, 53:792-807.
182. Williams V., White J., Schwaner T.D., Sparrow A. Variation in venom proteins from isolated populations of tiger snakes (Notechis ater niger, N. scutatus) in South Australia. Toxicon 1988, 26:1067-1075.
183. Daltry J.C., Wüster W., Thorpe R.S. Diet and snake venom evolution. Nature 1996, 379:537-540.
184. Barlow A., Pook C.E., Harrison R.A., Wüster W. Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution. Proc Biol Sci 2009, 276:2443-2449.
185. Calvete J.J., Sanz L., Cid P., de la Torre P., Flores-Diaz M., Dos Santos M.C., et al. Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America. J Proteome Res 2010, 9:528-544.
186. Calvete J.J., Sanz L., Perez A., Borges A., Vargas A.M., Lomonte B., et al. Snake population venomics and antivenomics of Bothrops atrox: paedomorphism along its transamazonian dispersal and implications of geographic venom variability on snakebite management. J Proteomics 2011, 74:510-527.
187. Wüster W., Ferguson J.E., Quijada-Mascarenas J.A., Pook C.E., Salomao Mda G., Thorpe R.S. Tracing an invasion: landbridges, refugia, and the phylogeography of the Neotropical rattlesnake (Serpentes: Viperidae: Crotalus durissus). Mol Ecol 2005, 14:1095-1108.
188. Saravia P., Rojas E., Arce V., Guevara C., Lopez J.C., Chaves E., et al. Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications. Rev Biol Trop 2002, 50:337-346.
189. Prasad N.B., Uma B., Bhatt S.K., Gowda V.T. Comparative characterisation of Russell's viper (Daboia-Vipera russelli) venoms from different regions of the Indian peninsula. Biochim Biophys Acta 1999, 1428:121-136.
190. Lanari L.C., Rosset S., Gonzalez M.E., Liria N., de Roodt A.R. A study on the venom of Bothrops alternatus Dumeril, Bibron and Dumeril, from different regions of Argentina. Toxicon 2010, 55:1415-1424.
191. Mackessy S.P. Evolutionary trends in venom composition in the western rattlesnakes (Crotalus viridis sensu lato): toxicity vs. tenderizers. Toxicon 2010, 55:1463-1474.
192. Zelanis A., Tashima A.K., Rocha M.M., Furtado M.F., Camargo A.C., Ho P.L., et al. Analysis of the ontogenetic variation in the venom proteome/peptidome of Bothrops jararaca reveals different strategies to deal with prey. J Proteome Res 2010, 9:2278-2291.
193. Changeux J.-P. The TiPS lecture the nicotinic acetylcholine receptor: an allosteric protein prototype of ligand-gated ion channels. Trends Pharmacol Sci 1990, 11:485-492.
194. Kini R.M., Doley R. Structure, function and evolution of three-finger toxins: mini proteins with multiple targets. Toxicon 2010, 56:855-867.
195. Ganthavorn S. Toxicities of Thailand snake venoms and neutralization capacity of antivenin. Toxicon 1969, 7:239-241.
196. Casasola A., Ramos-Cerrillo B., de Roodt A.R., Carbajal Saucedo A., Chippaux J.P., Alagon A., et al. Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: a comparative study. Toxicon 2009, 53:602-608.
197. Pillet L., Tremeau O., Ducancel F., Drevet P., Zinn-Justin S., Pinkasfeld S., et al. Genetic engineering of snake toxins. Role of invariant residues in the structural and functional properties of a curaremimetic toxin, as probed by site-directed mutagenesis. J Biol Chem 1993, 268:909-916.
198. Tremeau O., Lemaire C., Drevet P., Pinkasfeld S., Ducancel F., Boulain J.C., et al. Genetic engineering of snake toxins. The functional site of Erabutoxin a, as delineated by site-directed mutagenesis, includes variant residues. J Biol Chem 1995, 270:9362-9369.
199. Antil S., Servent D., Menez A. Variability among the sites by which curaremimetic toxins bind to torpedo acetylcholine receptor, as revealed by identification of the functional residues of alpha-cobratoxin. J Biol Chem 1999, 274:34851-34858.
200. Bourne Y., Talley T.T., Hansen S.B., Taylor P., Marchot P. Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors. EMBO J 2005, 24:1512-1522.
201. Dellisanti C.D., Yao Y., Stroud J.C., Wang Z.Z., Chen L. Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94A resolution. Nat Neurosci 2007, 10:953-962.
202. Tsetlin V., Utkin Y., Kasheverov I. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors. Biochem Pharmacol 2009, 78:720-731.
203. Balass M., Katchalski-Katzir E., Fuchs S. The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library. Proc Natl Acad Sci USA 1997, 94:6054-6058.
204. Balass M., Kalef E., Fuchs S., Katchalski-Katzir E. A cyclic peptide with high affinity to [alpha]-bungarotoxin protects mice from the lethal effect of the toxin. Toxicon 2001, 39:1045-1051.
205. Fuchs S., Kasher R., Balass M., Scherf T., Harel M., Fridkin M., et al. The binding site of acetylcholine receptor: from synthetic peptides to solution and crystal structure. Ann N Y Acad Sci 2003, 998:93-100.
206. Bracci L., Lozzi L., Lelli B., Pini A., Neri P. Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library. Biochemistry (Mosc) 2001, 40:6611-6619.
207. Bracci L., Lozzi L., Pini A., Lelli B., Falciani C., Niccolai N., et al. A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry (Mosc) 2002, 41:10194-10199.
208. Harrison R.A., Wster W., Theakston R.D.G. The conserved structure of snake venom toxins confers extensive immunological cross-reactivity to toxin-specific antibody. Toxicon 2003, 41:441-449.
209. Atassi M.Z. Antigenic structures of proteins. Their determination has revealed important aspects of immune recognition and generated strategies for synthetic mimicking of protein binding sites. Eur J Biochem 1984, 145:1-20.
210. Atassi M.Z., Dolimbek B.Z., Manshouri T. Antibody and T-cell recognition of [alpha]-bungarotoxin and its synthetic loop-peptides. Mol Immunol 1995, 32:919-929.
211. Dolimbek B.Z., Zouhair Atassi M. Protection against [alpha]-bungarotoxin poisoning by immunization with synthetic toxin peptides. Mol Immunol 1996, 33:681-689.
212. Cardoso R., Homsi-Brandeburgo M.I., Rodrigues V.M., Santos W.B., Souza G.L., Prudencio C.R., et al. Peptide mimicking antigenic and immunogenic epitope of neuwiedase from Bothrops neuwiedi snake venom. Toxicon 2009, 53:254-261.
213. Demangel C., Maroun R.C., Rouyre S., Bon C., Mazie J.C., Choumet V. Combining phage display and molecular modeling to map the epitope of a neutralizing antitoxin antibody. Eur J Biochem 2000, 267:2345-2353.
214. Moe G.R., Tan S., Granoff D.M. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol Med Microbiol 1999, 26:209-226.
215. Lesinski G.B., Smithson S.L., Srivastava N., Chen D., Widera G., Westerink M.A.J. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice. Vaccine 2001, 19:1717-1726.
216. Kulkeaw K., Sakolvaree Y., Srimanote P., Tongtawe P., Maneewatch S., Sookrung N., et al. Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin. J Proteomics 2009, 72:270-282.
217. Warrell D.A. Clinical toxicology of snakebite in Africa and the Middle East/Arabian Peninsula. Handbook of clinical toxicology of animal venoms and poisons 1995, 433-492. CRC Press, Boca Raton. 1st ed. J. Meier, J. White (Eds.).
218. Warrell D.A. Clinical toxicology of snakebite in Asia. Handbook of clinical toxicology of animal venoms and poisons 1995, 493-594. CRC Press, Boca Raton. 1st ed. J. Meier, J. White (Eds.).
219. Gutierrez J.M., Lomonte B., Leon G., Rucavado A., Chaves F., Angulo Y. Trends in snakebite envenomation therapy: scientific, technological and public health considerations. Curr Pharm Des 2007, 13:2935-2950.
220. Ownby C.L., Fletcher J.E., Colberg T.R. Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo. Toxicon 1993, 31:697-709.
221. Gutierrez J.M., Rucavado A., Chaves F., Diaz C., Escalante T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom. Toxicon 2009, 54:958-975.
222. Escalante T., Rucavado A., Pinto A.F., Terra R.M., Gutierrez J.M., Fox J.W. Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins. J Proteome Res 2009, 8:5120-5131.
223. Warrell D.A. Clinical features of envenoming from snake bites. Envenomings and their treatments 1996, 63-76. Fondation Marcel Mérieux, Lyon. C. Bon, M. Goyffon (Eds.).
224. Gutierrez J.M., Leon G., Rojas G., Lomonte B., Rucavado A., Chaves F. Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom. Toxicon 1998, 36:1529-1538.
225. Leon G., Valverde J.M., Rojas G., Lomonte B., Gutierrez J.M. Comparative study on the ability of IgG and Fab sheep antivenoms to neutralize local hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 2000, 38:233-244.
226. Leon G., Rojas G., Lomonte B., Gutierrez J. Immunoglobulin G and F(ab')2 polyvalent antivenoms do not differ in their ability to neutralize hemorrhage, edema and myonecrosis induced by Bothrops asper (terciopelo) snake venom. Toxicon 1997, 35:1627-1637.
227. Escalante T., Franceschi A., Rucavado A., Gutierrez J.M. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Biochem Pharmacol 2000, 60:269-274.
228. Rucavado A., Escalante T., Franceschi A., Chaves F., Leon G., Cury Y., et al. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Am J Trop Med Hyg 2000, 63:313-319.
229. Escalante T, Rucavado A, Fox JW, Gutierrez JM. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J Proteomics; in press.
230. Yingprasertchai S., Bunyasrisawat S., Ratanabanangkoon K. Hyaluronidase inhibitors (sodium cromoglycate and sodium auro-thiomalate) reduce the local tissue damage and prolong the survival time of mice injected with Naja kaouthia and Calloselasma rhodostoma venoms. Toxicon 2003, 42:635-646.
231. Murakami M.T., Arruda E.Z., Melo P.A., Martinez A.B., Calil-Elias S., Tomaz M.A., et al. Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin. J Mol Biol 2005, 350:416-426.
232. Lizano S., Domont G., Perales J. Natural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants. Toxicon 2003, 42:963-977.
233. Perales J., Neves-Ferreira A.G., Valente R.H., Domont G.B. Natural inhibitors of snake venom hemorrhagic metalloproteinases. Toxicon 2005, 45:1013-1020.
234. Gutierrez J.M., Theakston R.D., Warrell D.A. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med 2006, 3:e150.
235. Gutierrez J.M., Leon G., Burnouf T. Antivenoms for the treatment of snakebite envenomings: the road ahead. Biologicals 2011, 39:129-142.
236. Sharma S.K., Koirala S., Dahal G. Krait bite requiring high dose antivenom: a case report. Southeast Asian J Trop Med Public Health 2002, 33:170-171.
237. Yates V.M., Lebas E., Orpiay R., Bale B.J. Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania. Ann Trop Med Parasitol 2010, 104:439-448.
238. Ansah E.K., Narh-Bana S., Asiamah S., Dzordzordzi V., Biantey K., Dickson K., et al. Effect of removing direct payment for health care on utilisation and health outcomes in Ghanaian children: a randomised controlled trial. PLoS Med 2009, 6:e1000007.
239. Abdu Z., Mohammed Z., Bashier I., Eriksson B. The impact of user fee exemption on service utilization and treatment seeking behaviour: the case of malaria in Sudan. Int J Health Plann Manage 2004, 19(Suppl 1):S95-S106.
240. Balde M.C., Camara A.M., Bah H., Barry A.O., Camara S.K. Impact of snakebites in rural environment: community survey in the rural development community (DRC) of Frilguiagbe, Republic of Guinea. Bull Soc Pathol Exot 2005, 98:283-284.
241. Snow R.W., Bronzan R., Roques T., Nyamawi C., Murphy S., Marsh K. The prevalence and morbidity of snake bite and treatment-seeking behaviour among a rural Kenyan population. Ann Trop Med Parasitol 1994, 88:665-671.
242. Hati A.K., Mandal M., De M.K., Mukherjee H., Hati R.N. Epidemiology of snake bite in the district of Burdwan, West Bengal. J Indian Med Assoc 1992, 90:145-147.
243. Ghosh R.S. Q&A: Institute for OneWorld Health-fulfilling the promise of medicine for the developing world. Interview by Kyle Funk. Virulence 2010, 1:357-358.
244. Hale V.G., Woo K., Lipton H.L. Oxymoron no more: the potential of nonprofit drug companies to deliver on the promise of medicines for the developing world. Health Aff (Millwood) 2005, 24:1057-1063.
245. Zarocostas J. Gates Foundation pledges new funds to fight neglected diseases. BMJ 2009, 338:b454.
246. Cavalli A., Bamba S.I., Traore M.N., Boelaert M., Coulibaly Y., Polman K., et al. Interactions between Global Health Initiatives and country health systems: the case of a neglected tropical diseases control program in Mali. PLoS Negl Trop Dis 2010, 4:e798.
247. Gyapong J.O., Gyapong M., Yellu N., Anakwah K., Amofah G., Bockarie M., et al. Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. Lancet 2010, 375:160-165.
248. Slowinski J.B. A phylogenetic analysis of Bungarus (Elapidae) based on morphological characters. Herpetol J 1994, 28:440-446.
249. Kuch U., Mebs D. The identity of the Javan Krait, Bungarus javanicus Kopstein, 1932 (Squamata: Elapidae): evidence from mitochondrial and nuclear DNA sequence analyses and morphology. Zootaxa 2007, 1426:1-26.
250. Wallach V., Wüster W., Broadley D.G. In praise of subgenera: taxonomic status of cobras of the genus Naja Laurenti (Serpentes: Elapidae). Zootaxa 2009, 2236:26-36.
251. Malhotra A., Creer S., Pook C.E., Thorpe R.S. Inclusion of nuclear intron sequence data helps to identify the Asian sister group of New World pitvipers. Mol Phylogenet Evol 2010, 54:172-178.
252. Warrell D.A. Tropical snake bite: clinical studies in South East Asia. Natural toxins: animal, plant and microbial 1986, 25-45. Clarendon Press, Oxford. J.B. Harris (Ed.).
253. Warrell D.A., Looareesuwan S., White N.J., Theakston R.D.G., Warrell M.J., et al. Severe neurotoxic envenoming by the Malayan krait Bungarus candidus (Linnaeus): response to antivenom and anticholinesterase. Br Med J 1983, 286:678-680.
254. Tan C.H., Leong P.K., Fung S.Y., Sim S.M., Ponnudurai G., Ariaratnam C., et al. Cross neutralization of Hypnale hypnale (hump-nosed pit viper) venom by polyvalent and monovalent Malayan pit viper antivenoms in vitro and in a rodent model. Acta Trop 2011, 117:119-124.
255. Mebs D., Kornalik F. Schlangengiftseren: Probleme ihrer Wirksamkeit, untersucht am Beispiel von Echis carinatus. Salamandra 1981, 17:89-98.
256. Ramos-Cerrillo B., de Roodt A.R., Chippaux J.P., Olguin L., Casasola A., Guzman G., et al. Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Toxicon 2008, 52:881-888.
257. Mirtschin P.J., Dunstan N., Hough B., Hamilton E., Klein S., Lucas J., et al. Venom yields from Australian and some other species of snakes. Ecotoxicology 2006, 15:531-538.
258. Freyvogel T.A. Quantity and toxicity of Bitis lachesis venom. Acta Trop 1965, 22:267-269.
259. Marsh N.A., Whaler B.C. The Gaboon viper (Bitis gabonica): its biology, venom components and toxinology. Toxicon 1984, 22:669-694.
260. Pe Tun, Cho Khin Aung Amount of venom injected by Russell's viper (Vipera russelli). Toxicon 1986, 24:730-733.
261. Latifi M. Variation in yield and lethality of venoms from Iranian snakes. Toxicon 1984, 22:373-380.